Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-24 @ 3:54 PM
NCT ID:
NCT00970892
Eligibility Criteria:
Inclusion Criteria:
Patients who require warfarin for at least 6 months with the indications listed below:
* Permanent Atrial Fibrillation/Flutter
* Left atrial or ventricular thrombus
* Deep Vein Thrombosis
* Pulmonary Embolism
* Heart Valve Replacement (Mechanical or Biological With AF)
* Cardiomyopathy (Ischemic or Dilated)
* Peripheral Vascular Disease
Exclusion Criteria:
* History of GI bleeding or peptic ulcer disease
* Significant liver disease, active hepatitis or chronic HBV/HCV infection
* Uncontrolled hypertension
* Chronic diarrhea or malabsorption syndrome
* Viral or bacterial infection prior to enrollment
* Active or previous infective endocarditis
* Hospital stay \> 30 days as a result of septicemia, mediastinitis or pneumonia
* Cardiac cachexia
* Morbid obesity
* Expected pregnancy, pregnancy or lactation
* Psychiatric disease
* Malignancy with Life expectancy less than 1 year
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT00970892
Study Brief:
Protocol Section:
NCT00970892